Searched for
ALLERGAN SALES
Alembic Pharma gets USFDA nod for generic hypertension treatment capsulesAlembic Pharmaceuticals has received USFDA final approval for its generic Diltiazem Hydrochloride extended-release capsules in strengths of...- Alembic gets USFDA nod for Vilazodone Hydrochloride tablets used to treat depression"The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Viibryd tablets, 10 mg, 20 mg, and 40 mg, of A...
- Alembic Pharma gets tentative USFDA nod for ophthalmic solutionAlembic said it is currently in litigation with Allergan in District Court of New Jersey and the launch of this product will depend on the ...
- Lupin launches pain relieving generic tablets in USLupin's product is a generic version of Allergan Sales LLC's Norco tablets in the same strengths and is indicated for relief of moderate to...
- Allergan to buy Acelity's tissue unit LifeCell for $2.9 billionAllergan Chief Executive Brent Saunders has described the company's acquisition strategy as being one of "stepping stones." Allergan's deal...
- Lupin gets USFDA's final nod for pain relief tabletsThe tablets are generic version of Allergan Sales LLC's Norco tablets in the same strengths and the product will be launched shortly, Lupin...
- Cipla divests 16.7 per cent stake in Chase Pharma to AllerganChase was recently financed by a Series B consortium consisting of New Rhein Healthcare, Edmond de Rothschild Investment Partners and Cipla...
- Dr. Reddy’s buys eight ANDAs from Teva for $350 millionDr. Reddy’s said the acquisition of ANDAs is contingent on closing of the Teva generics transaction and approval by the US Federal Trade Co...
- Reckitt may consider buying Pfizer's unitReckitt Benckiser Group would consider acquiring Pfizer's consumer-health unit were it to come up for sale in the wake of the Viagra maker'...
- Brent Saunders gets key job as Pfizer, Allergan combineSaunders, 45, an intrepid deal maker, has a history of eventually leading companies that he had helped combine.
- Pfizer, allergan in talks to forge $330bn giant: WSJA bid for Allergan would be Pfizer's second attempt to acquire a European rival, following its unsuccessfully courtship of AstraZeneca Plc.
- Teva-Allergan deal a booster for Indian companiesTeva Pharmaceutical Industries’ $40.5-billion purchase of Allergan’s generics business may help Indian generic-drug makers acquire products
- Israel's Teva buys Allergan generic drug company for $40.5 billionTeva Pharmaceutical Industries Ltd. says it is purchasing Dublin-based Allergan PLC's generic pharmaceuticals business for $40.5 billion.
- Allergan Inc eyes Rs 1,000 crore in revenues from India by 2017-18"Our dream is to touch Rs 1,000 crore revenue figure by 2017-18. We are on track to get it on the back of what we have created here."
- Wellness market may touch $20 billion in next 3-4 yrsCurrently the size of the wellness market in India stood at about $ 10 billion, Allergan India Managing Director Raghu Kumar said.
- Allergan launches 'Juvederm XC' in IndiaUS-based Allergan Inc today announced the launch of its anaesthetic dermal filler 'Juvederm XC', used to correct facial imperfections, in t...
- Allergan to pay $600-mn fine in Botox probeAllergan, maker of the wrinkle smoother Botox, agreed to pay $600 million and plead guilty to a single misdemeanour charge in settling a US...
- Allergan to introduce more products for enhancing businessUS-based pharmaceutical firm Allergan today said that it is looking at expanding its product range in India as part of a strategy to enhanc...
- Allegran arm to sell Botox productsAmerican drug company Allergan Pharmaceuticals is setting up a wholly-owned subsidiary to sell Botox products, used as muscle relaxants and...
- Allergan opens pharma R&D company in IndiaUS-based Allergan Inc today launched a pharmaceutical research and development (R&D) firm here.
Load More
